Anqing Echo Biopharmaceutical

Anqing Echo Biopharmaceutical (Anqing Echo Pharmaceutical Co., Ltd.) is a comprehensive pharmaceutical company based in Anqing, Anhui Province, China. Formed through the restructuring of the state-owned Anqing Fourth Pharmaceutical Factory, the company specializes in the research, development, manufacturing, and commercialization of traditional Chinese medicines (TCM), chemical raw materials, and pharmaceutical formulations. Its extensive product portfolio spans multiple therapeutic areas, including gynecology, oncology, cardiovascular, respiratory, and anti-allergy. Key commercial products include Tropisetron Hydrochloride Injection for chemotherapy-induced nausea and vomiting, Levocarnitine Injection, and Duanxueliu Tablets for gynecological bleeding. The company operates multiple manufacturing bases and production lines across Anhui, Jiangxi, and Zhejiang provinces, complying with national GMP standards.